Shahid Beheshti University Of Medical Sciences

This study looked at whether adding empagliflozin (a diabetes medicine) to insulin can reduce oxidative stress—a type of cell damage—in people with type 2 diabetes who have received a kidney transplant. Forty adults with stable graft function took either empagliflozin plus insuli…